Cargando…

Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study

Rheumatoid arthritis (RA) is associated with neuroendocrine and immunologic dysfunction leading to rheumatoid cachexia. Although excess proinflammatory cytokines can decrease somatotropic axis activity, little is known about the effects of RA on growth hormone/insulin-like growth factor-1 (GH/IGF-I)...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackman, Marc R, Muniyappa, Ranganath, Wilson, Mildred, Moquin, Barbara E, Baldwin, Howard L, Wong, Kelli A, Snyder, Christopher, Magalnick, Michael, Alli, Shaan, Reynolds, James, Steinberg, Seth M, Goldbach-Mansky, Raphaela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206381/
https://www.ncbi.nlm.nih.gov/pubmed/17662149
http://dx.doi.org/10.1186/ar2271
_version_ 1782148458427187200
author Blackman, Marc R
Muniyappa, Ranganath
Wilson, Mildred
Moquin, Barbara E
Baldwin, Howard L
Wong, Kelli A
Snyder, Christopher
Magalnick, Michael
Alli, Shaan
Reynolds, James
Steinberg, Seth M
Goldbach-Mansky, Raphaela
author_facet Blackman, Marc R
Muniyappa, Ranganath
Wilson, Mildred
Moquin, Barbara E
Baldwin, Howard L
Wong, Kelli A
Snyder, Christopher
Magalnick, Michael
Alli, Shaan
Reynolds, James
Steinberg, Seth M
Goldbach-Mansky, Raphaela
author_sort Blackman, Marc R
collection PubMed
description Rheumatoid arthritis (RA) is associated with neuroendocrine and immunologic dysfunction leading to rheumatoid cachexia. Although excess proinflammatory cytokines can decrease somatotropic axis activity, little is known about the effects of RA on growth hormone/insulin-like growth factor-1 (GH/IGF-I) axis function. We tested the hypothesis that patients with active RA exhibit decreased GH/IGF-I axis activity. To do so, we conducted a pilot case-control study at a clinical research center in 7 pre- and perimenopausal women with active RA and 10 age- and body mass index-matched healthy women. Participants underwent blood sampling every 20 minutes for 24 hours (8 a.m. to 8 a.m.), and sera were assayed for GH, cortisol, and dehydroepiandrosterone (DHEA). Sera obtained after overnight fasting were assayed for IGF-I, IGF-binding protein (IGFBP)-1, IGFBP-3, C-reactive protein (CRP), interleukin-6 (IL-6), glucose, insulin, and lipids. Body composition and bone mineral density were evaluated by DEXA (dual emission x-ray absorptiometry) scans. In patients with RA, mean disease duration was 7.6 ± 6.8 years, and erythrocyte sedimentation rate, CRP, and IL-6 were elevated. GH half-life was shorter than in control subjects (p = 0.0037), with no other significant group differences in GH deconvolution parameters or approximate entropy scores. IGF-I (p = 0.05) and IGFBP-3 (p = 0.058) were lower, whereas IGFBP-1 tended to be higher (p = 0.066), in patients with RA, with nonsignificantly increased 24-hour total GH production rates. There were no significant group differences in cortisol or DHEA secretion. Lean body mass was lower in patients with RA (p = 0.019), particularly in the legs (p = 0.01). Women with active RA exhibit a trend toward GH insensitivity and relatively diminished diurnal cortisol and DHEA secretion for their state of inflammation. Whether these changes contribute to rheumatoid cachexia remains to be determined. NCT00034060.
format Text
id pubmed-2206381
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22063812008-01-19 Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study Blackman, Marc R Muniyappa, Ranganath Wilson, Mildred Moquin, Barbara E Baldwin, Howard L Wong, Kelli A Snyder, Christopher Magalnick, Michael Alli, Shaan Reynolds, James Steinberg, Seth M Goldbach-Mansky, Raphaela Arthritis Res Ther Research Article Rheumatoid arthritis (RA) is associated with neuroendocrine and immunologic dysfunction leading to rheumatoid cachexia. Although excess proinflammatory cytokines can decrease somatotropic axis activity, little is known about the effects of RA on growth hormone/insulin-like growth factor-1 (GH/IGF-I) axis function. We tested the hypothesis that patients with active RA exhibit decreased GH/IGF-I axis activity. To do so, we conducted a pilot case-control study at a clinical research center in 7 pre- and perimenopausal women with active RA and 10 age- and body mass index-matched healthy women. Participants underwent blood sampling every 20 minutes for 24 hours (8 a.m. to 8 a.m.), and sera were assayed for GH, cortisol, and dehydroepiandrosterone (DHEA). Sera obtained after overnight fasting were assayed for IGF-I, IGF-binding protein (IGFBP)-1, IGFBP-3, C-reactive protein (CRP), interleukin-6 (IL-6), glucose, insulin, and lipids. Body composition and bone mineral density were evaluated by DEXA (dual emission x-ray absorptiometry) scans. In patients with RA, mean disease duration was 7.6 ± 6.8 years, and erythrocyte sedimentation rate, CRP, and IL-6 were elevated. GH half-life was shorter than in control subjects (p = 0.0037), with no other significant group differences in GH deconvolution parameters or approximate entropy scores. IGF-I (p = 0.05) and IGFBP-3 (p = 0.058) were lower, whereas IGFBP-1 tended to be higher (p = 0.066), in patients with RA, with nonsignificantly increased 24-hour total GH production rates. There were no significant group differences in cortisol or DHEA secretion. Lean body mass was lower in patients with RA (p = 0.019), particularly in the legs (p = 0.01). Women with active RA exhibit a trend toward GH insensitivity and relatively diminished diurnal cortisol and DHEA secretion for their state of inflammation. Whether these changes contribute to rheumatoid cachexia remains to be determined. NCT00034060. BioMed Central 2007 2007-07-28 /pmc/articles/PMC2206381/ /pubmed/17662149 http://dx.doi.org/10.1186/ar2271 Text en Copyright © 2007 Blackman et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Blackman, Marc R
Muniyappa, Ranganath
Wilson, Mildred
Moquin, Barbara E
Baldwin, Howard L
Wong, Kelli A
Snyder, Christopher
Magalnick, Michael
Alli, Shaan
Reynolds, James
Steinberg, Seth M
Goldbach-Mansky, Raphaela
Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
title Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
title_full Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
title_fullStr Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
title_full_unstemmed Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
title_short Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
title_sort diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206381/
https://www.ncbi.nlm.nih.gov/pubmed/17662149
http://dx.doi.org/10.1186/ar2271
work_keys_str_mv AT blackmanmarcr diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT muniyapparanganath diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT wilsonmildred diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT moquinbarbarae diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT baldwinhowardl diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT wongkellia diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT snyderchristopher diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT magalnickmichael diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT allishaan diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT reynoldsjames diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT steinbergsethm diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy
AT goldbachmanskyraphaela diurnalsecretionofgrowthhormonecortisolanddehydroepiandrosteroneinpreandperimenopausalwomenwithactiverheumatoidarthritisapilotcasecontrolstudy